Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Alper H.YUKSEL who wrote (26881)	12/13/1998 9:44:00 AM
From: smh	Read Replies (1) \| Respond to of 32384

Just as governments can print money, companies can print stock. It is not clear to me how far LGND can get following a consolidation strategy, but I would not underestimate it. I am sure he will correct me if I do not get this right (for which I apologize in advance), but I believe this is exactly Richard Harmon's concern with LGND - that Robinson's intent is to grow the company through the continued issuance of stock, which if not dilutive, will at least prevent current shareholders from seeing any appreciation.

To: Alper H.YUKSEL who wrote (26881)	12/13/1998 10:30:00 AM
From: aknahow	Respond to of 32384

Alper, I second your thoughts. I hope this is one of Murphy's own misstatements and not something LGND itself is promoting. Yes, I do remember they talked of using some of the funds for acquisitions but, was thinking at most that meant small niche deals.

To: Alper H.YUKSEL who wrote (26881)	12/13/1998 12:20:00 PM
From: Henry Niman	Respond to of 32384

Alper, When LGND announced the deal with ELN, they indicated that they were looking to do some acquiring, which or course can be done with cash or stock. LGND's cash pockets are not as deep as AMGN or CHIR, but the bigger Biotechs haven't done that much acquiring in the past, while LGND has acquired GLYC (1995), ALRI (1997), and SRGN (1998) so far.

To: Alper H.YUKSEL who wrote (26881)	12/13/1998 1:34:00 PM
From: bob smith	Read Replies (2) \| Respond to of 32384

I thought I have a look and make a comparison between the three biotechs; --------Market cap.------Employees Amgen 21.000 million----5300(?) Chiron --4.4oo million----6400 Ligand---- 494 million------380 MM must have thought of another company when he mentioned Ligand.. Or could it be that LGND burned such a sizable hole in his pocket,(what is the case with many of us)that he is now forced to go to great lengths to help bring back the stock, so to minimize the damage?.. But I doubt that someone of his stature would in his desperate attempts to work up the stock, lover himself to such a degree (most familiar to us) and just start hyping it, by placing it next to Amgen and Chiron... And as I glanced over our board here, MM's comments sure managed to reignite OUR old hype machine...:)